Oslo, 30 April 30 2024 - Navamedic ASA has today published its Annual Report
for 2023 approved by the Board of Directors. Find enclosed the report in PDF as
well as an ESEF file version. The report is also made available at the company's
website at https://navamedic.com/investors/annual-reports/
For further information, please contact:
Kathrine Gamborg Andreassen, CEO, Navamedic Mobile: +47 951 78 680 E-mail:
kathrine@navamedic.com
Lars Hjarrand, CFO, Navamedic Mobile: +47917 62 842 E-mail:
lars.hjarrand@navamedic.com
About Navamedic
Navamedic ASA is a full-service provider of high-quality healthcare products to
hospitals and pharmacies. Navamedic meets the specific medical needs of patients
and consumers by leveraging its highly scalable market access platform, leading
category competence and local knowledge. Navamedic is present in all the Nordic
countries, the Baltics and Benelux, with sales representation in the UK and
Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock
Exchange (ticker: NAVA). For more information, please visit www.navamedic.com.
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.